Key facts
- Notable investors include EcoPro Partners.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Kolab
- ·The full record, as it builds
Funding rounds
No funding rounds for Kolab are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Kolab
Operator of a clinical trial management organization intended to support studies in geriatric brain conditions and digital healthcare devices. The company offers cohort-based recruitment, tailored trial planning, and subject monitoring, enabling medical device and pharmaceutical developers focused on brain-related aging disorders to conduct trials with greater efficiency and oversight.
- Sector
- Healthcare
- HQ
- Gwangju, South Korea
- Founded
- 2020
- Website
- kolabcro.com/
- Ownership
- Privately Held (backing)
Kolab doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Kolab shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Kolab in its N-PORT filings yet. We sweep new filings monthly.